Macerich (NYSE:MAC – Get Free Report) had its price objective cut by analysts at The Goldman Sachs Group from $16.70 to $14.40 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “sell” rating on the real estate investment trust’s stock. The Goldman Sachs Group’s target price would indicate a potential downside of 9.41% from the stock’s previous close.
Other analysts have also issued reports about the stock. Scotiabank cut their price target on shares of Macerich from $22.00 to $21.00 and set a “sector perform” rating for the company in a research report on Thursday. Piper Sandler dropped their target price on Macerich from $17.00 to $16.00 and set an “underweight” rating for the company in a report on Friday, February 28th. Mizuho raised Macerich from an “underperform” rating to a “neutral” rating and lifted their price target for the stock from $14.00 to $22.00 in a research note on Wednesday, December 4th. Morgan Stanley upgraded shares of Macerich from an “underweight” rating to an “equal weight” rating and set a $20.00 target price on the stock in a report on Wednesday, January 15th. Finally, Deutsche Bank Aktiengesellschaft began coverage on shares of Macerich in a research note on Tuesday, December 17th. They issued a “hold” rating and a $22.00 target price on the stock. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $19.03.
Check Out Our Latest Stock Report on Macerich
Macerich Price Performance
Insider Activity at Macerich
In related news, Director Andrea M. Stephen sold 63,289 shares of the business’s stock in a transaction that occurred on Thursday, December 26th. The stock was sold at an average price of $20.59, for a total transaction of $1,303,120.51. Following the completion of the sale, the director now owns 83,479 shares in the company, valued at $1,718,832.61. The trade was a 43.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is owned by insiders.
Hedge Funds Weigh In On Macerich
A number of hedge funds have recently modified their holdings of MAC. Citigroup Inc. lifted its holdings in shares of Macerich by 32.3% during the third quarter. Citigroup Inc. now owns 359,069 shares of the real estate investment trust’s stock worth $6,549,000 after purchasing an additional 87,611 shares during the period. Quest Partners LLC lifted its position in Macerich by 851.9% in the third quarter. Quest Partners LLC now owns 30,529 shares of the real estate investment trust’s stock valued at $557,000 after purchasing an additional 27,322 shares during the period. Bamco Inc. NY increased its position in Macerich by 742.3% during the 3rd quarter. Bamco Inc. NY now owns 1,695,420 shares of the real estate investment trust’s stock worth $30,924,000 after purchasing an additional 1,494,145 shares during the period. Friedenthal Financial acquired a new stake in shares of Macerich in the 4th quarter valued at approximately $771,000. Finally, Smead Capital Management Inc. lifted its holdings in shares of Macerich by 3.5% in the 3rd quarter. Smead Capital Management Inc. now owns 20,433,449 shares of the real estate investment trust’s stock valued at $372,706,000 after buying an additional 688,790 shares during the period. 87.38% of the stock is currently owned by hedge funds and other institutional investors.
About Macerich
Macerich is a fully integrated, self-managed and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich’s portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, DC corridor.
Further Reading
- Five stocks we like better than Macerich
- How is Compound Interest Calculated?
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- The Risks of Owning Bonds
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
- Where to Find Earnings Call Transcripts
- Energy and Basic Materials Sectors Will Dominate in 2025
Receive News & Ratings for Macerich Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Macerich and related companies with MarketBeat.com's FREE daily email newsletter.